[Percutaneous tumor ablation therapy for the advanced stage of HCC]

Hepatocellular carcinoma depicted as hypoattenuation on CT hepatic arteriography (CTA) and hyperattenuation on CT during arterial portography (CTAP).

[Management of complications associated with local ablation therapy for hepatocellular carcinoma]

Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver.

Clinical features of patients with HCC who are negative for both HBV and HCV markers.

Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma.

A novel display of reconstruction computed tomography for the detection of small hepatocellular carcinoma.

Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.

Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence.

Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography.